VectivBio Holding AG (VECT) Prices $125 Million Underwritten Offering of Ordinary Shares at $7 50/sh streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
VectivBio Raises $125 Million After Reporting Positive Results from Phase 2 Study of Apraglutide in SBS globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
The stunning fall in Klarna’s valuation, and further cuts to some estimates of Canva’s valuation, suggest the tech pain in public markets has infected private ones.
BASEL, Switzerland, June 29, 2022 (GLOBE NEWSWIRE) VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, announces it has closed